AssetMark’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.5K Buy
135
+40
+42% +$738 ﹤0.01% 2984
2026
Q2
$1.69K Buy
95
+2
+2% +$32 ﹤0.01% 3013
2026
Q1
$1.33K Buy
93
+2
+2% +$33 ﹤0.01% 2970
2025
Q4
$1.6K Hold
91
– – ﹤0.01% 2823
2025
Q3
$1.43K Hold
91
– – ﹤0.01% 2705
2025
Q2
$1.01K Buy
91
+58
+176% +$679 ﹤0.01% 2611
2025
Q1
$385 Hold
33
– – ﹤0.01% 2460
2024
Q4
$451 Buy
+33
New +$478 ﹤0.01% 2392

Other funds holding SHC

AssetMark's SHC Position: Q3 2026 in Review

AssetMark increased its Sotera Health (SHC) stake by 42% in Q3 2026, buying an estimated $738 and bringing the position to 135 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2984.

AssetMark first reported a position in SHC in Q4 2024 and has held it in 8 quarters since. 261 funds tracked by Wall St. Rank hold SHC as of Q3 2026.

  • AssetMark held 135 shares of Sotera Health worth $2.5K as of Q3 2026.
  • AssetMark bought 40 Sotera Health shares in Q3 2026, an estimated $738.
  • Sotera Health made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2984 holding.
  • AssetMark first reported a position in Sotera Health in Q4 2024 and has held it in 8 quarters since.
  • 261 funds tracked by Wall St. Rank held Sotera Health as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.